WEIGHT-LOSS DRUGS' IMPACT ON CANCER RISK REVEALED IN NEW STUDY The National Institutes of Health (NIH) published research in June 2024 that considered the correlation between semaglutide therapy and "exacerbating mood disturbances." The study highlighted the association of negative mood changes in patients with type 2 diabetes with a history of depression, warning healthcare providers to be aware of this "potential risk." But a more recent study, published in the journal Diabetes, Obesity and Metabolism, suggested that these mood changes were linked to genetic variations across diverse populations and ancestries within the U.K
The Future of Regenerative Peptide Medicine Peptides like GHK-Cu represent a broader shift in medicine toward signaling-based therapeuticsmolecules that guide biological repair rather than simply suppress symptoms
These results again are not a new discovery and only act to strengthen the existing literature and our previous findings that T2DM individuals have an overproduction of ROS and proinflammatory cytokines, while also having decreased levels of GSH
Methods (San Diego, Calif.) 114:7484
It plays a vital role in protecting cells from oxidative stress, which occurs when there is an imbalance between free radicals and antioxidants
During those years, silent damage continued in their kidneys, eyes and nerves
